Alchemab Therapeutics CEO to Present at Wells Fargo 2023 Healthcare Conference

Cambridge, UK, September 5, 2023 – Alchemab Therapeutics, an antibody discovery company identifying naturally occurring antibodies from individuals resilient to disease, today announced that Young Kwon, PhD, Chief Executive Officer, will participate in a fireside chat at the Wells Fargo 2023 Healthcare Conference on 7 September 2023 at 4:30 p.m. ET.

Dr. Kwon will be discussing Alchemab’s antibody discovery platform and lead preclinical programs for frontotemporal dementia/amyotrophic lateral sclerosis, Alzheimer’s disease and Huntington’s disease. A live audio webcast of the presentation can be accessed via Alchemab’s website at https://www.alchemab.com/events-presentations/.

The webcast will be archived for 90 days following the live presentation.